Inhibition of influenza virus production in virus-infected mice by RNA interference.

Influenza A virus infection is a major source of morbidity and mortality worldwide. Because the effectiveness of existing vaccines and antiviral drugs is limited, development of new treatment modalities is needed. Here, we show that short interfering RNAs (siRNAs) specific for conserved regions of influenza virus genes can prevent and treat influenza virus infection in mice. Virus production in lungs of infected mice is reduced by siRNAs given either before or after initiating virus infection, by using slow i.v. administration of small volumes containing siRNAs in complexes with a polycation carrier. Similar effects also are observed when mice are given DNA vectors i.v. or intranasally, from which siRNA precursors can be transcribed. Development of delivery systems that may be compatible with human use demonstrates the potential utility of siRNAs for prophylaxis and therapy of influenza virus infections in humans.

[1]  Judy Lieberman,et al.  RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.

[2]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[3]  C. Rice,et al.  Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Tumpey,et al.  Protection against lethal influenza virus challenge by RNA interference in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Merlo,et al.  Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.

[6]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[7]  K. Saksela.  Human viruses under attack by small inhibitory RNA. , 2003, Trends in microbiology.

[8]  Mamoru Watanabe,et al.  Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs , 2003, EMBO reports.

[9]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[10]  Robert H. Silverman,et al.  Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.

[11]  Michael T. McManus,et al.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.

[12]  M. Diamond,et al.  The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. , 2003, Virology.

[13]  S. Hammond,et al.  RNA interference: a promising approach to antiviral therapy? , 2002, Trends in molecular medicine.

[14]  W. P. Glezen,et al.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.

[15]  Douglas S. Conklin,et al.  Gene expression: RNA interference in adult mice , 2002, Nature.

[16]  P. Factor,et al.  Comparison of surfactant and perfluorochemical liquid enhanced adenovirus-mediated gene transfer in normal rat lung. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  K. Mozdzanowska,et al.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.

[18]  S. Brantl,et al.  Antisense-RNA regulation and RNA interference. , 2002, Biochimica et biophysica acta.

[19]  Michael R. Green,et al.  Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). , 2004, RNA.

[20]  F. Chisari,et al.  Interference of hepatitis C virus RNA replication by short interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Howard Y. Chang,et al.  Genomewide view of gene silencing by small interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  John J Rossi,et al.  Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase , 2004, Nature Biotechnology.

[23]  S. W. Kim,et al.  Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  S. Fesik,et al.  Specificity of short interfering RNA determined through gene expression signatures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Ferrari,et al.  Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. , 1999, Biochimica et biophysica acta.

[26]  P. Sharp,et al.  RNA interference--2001. , 2001, Genes & development.

[27]  B. Cullen,et al.  Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary Macrophages by Using Tat- or CCR5-Specific Small Interfering RNAs Expressed from a Lentivirus Vector , 2003, Journal of Virology.

[28]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[29]  K. D. Patterson,et al.  The geography and mortality of the 1918 influenza pandemic. , 1991, Bulletin of the history of medicine.

[30]  A. Boletta,et al.  Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs , 1999, Gene Therapy.

[31]  Michael T. McManus,et al.  RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Stiver.  The treatment of influenza with antiviral drugs. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[33]  J. Behr,et al.  Systemic linear polyethylenimine (L‐PEI)‐mediated gene delivery in the mouse , 2000, The journal of gene medicine.

[34]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[35]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[36]  David L. Lewis,et al.  Efficient delivery of siRNA for inhibition of gene expression in postnatal mice , 2002, Nature Genetics.

[37]  G. Levi,et al.  Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes , 2000, Gene Therapy.

[38]  A. Kendal,et al.  Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. , 1985, JAMA.

[39]  K. Subbarao,et al.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. , 2002, Emerging infectious diseases.

[40]  H. Vaucheret,et al.  Post-transcriptional gene silencing in plants. , 2001, Journal of cell science.

[41]  S. Barik,et al.  Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses , 2001, BMC Microbiology.